A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation (Solstice)
This study has been completed.
First Posted: June 1, 2009
Last Update Posted: January 30, 2017
Information provided by (Responsible Party):